Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity - Frontiers in Endocrinology Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity - JAMA Internal Medicine Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes - New England Journal of Medicine Tirzepatide for Diabetes Improves Glycemic Control After Switch From GLP-1RA - Endocrinology Advisor Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension - Diabetes, Obesity and Metabolism
for example, Wegovy lists around $1,350 per month retail, while generic liraglutide options can be available around $470 per month, and those differences often determine which regimen patients actually use
If you have type 2 diabetes, your body may not be responding to GLP-1 properly
1,3 *Efficacy estimand: This analysis was not included in the statistical testing hierarchy, and as such, is hypothetical and was not controlled for multiplicity
